NCT05987332 · Interventional trial
IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal Melanoma
Overall registry status Active not recruiting
Phase 2 · Phase 3
Conditions Metastatic Uveal Melanoma
Delaware Valley sites
- Thomas Jefferson University · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory